Letter: bleeding in cirrhotics receiving coronary stenting and antiplatelet therapy - author's reply

被引：0
|
作者：
Feagins, L. A. [1 ,2 ]
机构：
[1] VA North Texas Healthcare Syst, Div Gastroenterol & Hepatol, Dallas, TX 75216 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2017年 / 46卷 / 07期
关键词：
D O I：
10.1111/apt.14258
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：710 / 710
页数：1
相关论文
共 50 条
  • [1] Letter: bleeding in cirrhotics receiving coronary stenting and antiplatelet therapy
    Ponzetto, A.
    Figura, N.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (07) : 709 - 709
  • [2] Upper Gastrointestinal Bleeding in Patients Receiving Dual Antiplatelet Therapy after Coronary Stenting
    Yasuda, Hiroshi
    Yamada, Masaya
    Sawada, Susumu
    Endo, Yutaka
    Inoue, Kazuaki
    Asano, Fuyuki
    Takeyama, Youichi
    Yoshiba, Makoto
    INTERNAL MEDICINE, 2009, 48 (19) : 1725 - 1730
  • [3] Bedside Monitoring of Antiplatelet Therapy for Coronary Stenting Reply
    Montalescot, Gilles
    Vicaut, Eric
    Collet, Jean-Philippe
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (09): : 871 - 872
  • [4] Antiplatelet and anticoagulant therapy after coronary-artery stenting - Reply
    Neumann, FJ
    Walter, H
    Schomig, A
    NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (15): : 1161 - 1161
  • [5] Antiplatelet therapy for coronary stenting.
    Barragan, P
    Pietri, P
    Villain, P
    Silvestri, M
    Roquebert, PO
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1996, 89 (11): : 1515 - 1520
  • [6] Antiplatelet therapy after coronary stenting
    Galper B.Z.
    Mauri L.
    Current Treatment Options in Cardiovascular Medicine, 2013, 15 (1) : 1 - 10
  • [7] REPLY: The Optimal Duration of Dual- Antiplatelet Therapy After Coronary Stenting
    Palmerini, Tullio
    Biondi-Zoccai, Giuseppe
    Stone, Gregg W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (17) : 2210 - 2211
  • [8] Intensity of dual antiplatelet therapy based on thrombotic and bleeding risks after coronary stenting
    Kim, J. S.
    Jeong, Y. H.
    Ahn, J. H.
    Kang, M. G.
    Koh, J. S.
    Park, Y. W.
    Hwang, S. J.
    Hwang, J. Y.
    Park, Y. H.
    Hwang, K. W.
    Lee, S. H.
    Lee, S. Y.
    Choi, J. H.
    Kim, S. H.
    Lim, J. H.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [9] Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary Stenting
    Costa, Francesco
    Van Klaveren, David
    Feres, Fausto
    James, Stefan
    Raber, Lorenz
    Pilgrim, Thomas
    Hong, Myeong-Ki
    Kim, Hyo-Soo
    Colombo, Antonio
    Steg, Philippe Gabriel
    Bhatt, Deepak L.
    Stone, Gregg W.
    Windecker, Stephan
    Steyerberg, Ewout W.
    Valgimigli, Marco
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (07) : 741 - 754
  • [10] Dual antiplatelet therapy after coronary stenting
    Park, Yongwhi
    Franchi, Francesco
    Rollini, Fabiana
    Angiolillo, Dominick J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (13) : 1775 - 1787
12345